A detailed history of Empirical Financial Services, LLC D.B.A. Empirical Wealth Management transactions in Pfizer Inc stock. As of the latest transaction made, Empirical Financial Services, LLC D.B.A. Empirical Wealth Management holds 43,680 shares of PFE stock, worth $1.12 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
43,680
Previous 45,831 4.69%
Holding current value
$1.12 Million
Previous $1.28 Million 1.4%
% of portfolio
0.04%
Previous 0.04%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$27.7 - $31.39 $59,582 - $67,519
-2,151 Reduced 4.69%
43,680 $1.26 Million
Q2 2024

Aug 09, 2024

BUY
$25.26 - $29.6 $51,934 - $60,857
2,056 Added 4.7%
45,831 $1.28 Million
Q1 2024

May 06, 2024

SELL
$25.89 - $29.73 $190,653 - $218,931
-7,364 Reduced 14.4%
43,775 $1.21 Million
Q4 2023

Feb 06, 2024

SELL
$26.13 - $33.94 $85,288 - $110,780
-3,264 Reduced 6.0%
51,139 $1.47 Million
Q3 2023

Nov 02, 2023

SELL
$32.09 - $37.51 $198,669 - $232,224
-6,191 Reduced 10.22%
54,403 $1.8 Million
Q2 2023

Aug 11, 2023

SELL
$36.12 - $41.79 $2.21 Million - $2.56 Million
-61,143 Reduced 50.23%
60,594 $2.22 Million
Q1 2023

May 09, 2023

SELL
$39.39 - $51.28 $73,698 - $95,944
-1,871 Reduced 1.51%
121,737 $4.97 Million
Q4 2022

Feb 07, 2023

BUY
$41.75 - $54.5 $190,380 - $248,520
4,560 Added 3.83%
123,608 $6.34 Million
Q3 2022

Nov 02, 2022

BUY
$43.76 - $53.42 $888,459 - $1.08 Million
20,303 Added 20.56%
119,048 $5.21 Million
Q2 2022

Aug 02, 2022

BUY
$46.53 - $55.17 $1.71 Million - $2.02 Million
36,650 Added 59.02%
98,745 $5.18 Million
Q1 2022

May 13, 2022

SELL
$45.75 - $56.69 $58,331 - $72,279
-1,275 Reduced 2.01%
62,095 $3.22 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $179,700 - $266,376
4,349 Added 7.37%
63,370 $3.74 Million
Q3 2021

Nov 02, 2021

BUY
$39.25 - $50.42 $104,836 - $134,671
2,671 Added 4.74%
59,021 $2.54 Million
Q2 2021

Aug 12, 2021

BUY
$35.91 - $40.68 $158,506 - $179,561
4,414 Added 8.5%
56,350 $2.21 Million
Q1 2021

May 17, 2021

SELL
$33.49 - $37.77 $777,403 - $876,755
-23,213 Reduced 30.89%
51,936 $1.88 Million
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $235,193 - $299,069
7,027 Added 10.32%
75,149 $2.77 Million
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $16,065 - $18,848
-506 Reduced 0.74%
68,122 $2.5 Million
Q2 2020

Aug 12, 2020

BUY
$30.12 - $36.54 $361,138 - $438,114
11,990 Added 21.17%
68,628 $2.24 Million
Q1 2020

May 11, 2020

BUY
$27.03 - $38.62 $106,254 - $151,815
3,931 Added 7.46%
56,638 $1.85 Million
Q4 2019

Feb 13, 2020

BUY
$32.92 - $37.36 $546,011 - $619,652
16,586 Added 45.92%
52,707 $2.07 Million
Q3 2019

Nov 13, 2019

SELL
$32.49 - $42.13 $176,615 - $229,018
-5,436 Reduced 13.08%
36,121 $1.3 Million
Q2 2019

Aug 12, 2019

BUY
$36.98 - $41.52 $400,308 - $449,454
10,825 Added 35.22%
41,557 $1.8 Million
Q1 2019

May 13, 2019

BUY
$37.5 - $41.2 $124,725 - $137,031
3,326 Added 12.14%
30,732 $1.31 Million
Q4 2018

Feb 13, 2019

BUY
$38.47 - $43.86 $157,226 - $179,255
4,087 Added 17.53%
27,406 $1.2 Million
Q3 2018

Nov 13, 2018

BUY
$34.47 - $41.81 $231,052 - $280,252
6,703 Added 40.34%
23,319 $1.03 Million
Q2 2018

Aug 13, 2018

BUY
$32.98 - $35.16 $254,110 - $270,907
7,705 Added 86.47%
16,616 $603,000
Q1 2018

May 14, 2018

BUY
$31.91 - $37.02 $48,056 - $55,752
1,506 Added 20.34%
8,911 $316,000
Q1 2018

May 14, 2018

BUY
$31.91 - $37.02 $9,445 - $10,957
296 Added 4.16%
7,405 $316,000
Q4 2017

Feb 12, 2018

SELL
$33.26 - $35.29 $9,944 - $10,551
-299 Reduced 4.04%
7,109 $257,000
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $8,401 - $9,254
271 Added 3.8%
7,408 $264,000
Q2 2017

Aug 10, 2017

BUY
N/A
7,137
7,137 $240,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $144B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Empirical Financial Services, LLC D.B.A. Empirical Wealth Management Portfolio

Follow Empirical Financial Services, LLC D.B.A. Empirical Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Financial Services, LLC D.B.A. Empirical Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Financial Services, LLC D.B.A. Empirical Wealth Management with notifications on news.